1Serruys PW. ARTS I - the rapamycin eluting stent; ARTS II - the rosy prophecy. Eur Heart J, 2002, 23: 757-759. 被引量：1
2Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349:1315-1323. 被引量：1
3Ruygrok PN, Muller DW, Serruys PW. Rapamycin in cardiovascular medicine. Intern Med J, 2003, 33:103-109. 被引量：1
4Lemos PA, Lee CH, Degertekin M, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. J Am Coll Cardiol, 2003, 41:2093-2099. 被引量：1
5Lefevre T,Louvard Y,Morice MC,et al.In-stent restenosis:Should we stent the stent? A single center prospective study.Circulation,1997,96:1-88. 被引量：1
6Morice MC,Serruys PW,Sousa JE,et al.A randomized comparision of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med,2002,346:1773-1780. 被引量：2
7Moses JW,Shaughnessy C,Caputo R,et al.The US multiceter,randomized,double-blind study of the sirolimus-eluting stent in coronary lesions:safety outcomes at 9 months.Eur Heart J ,2002,23 (Suppl):264. 被引量：2
8Degertekin M,Regar E,Smits PC,et al.Sirolimus-eluting stent for treatment of in-stent restenosis: the first European clinical experience.Eur Heart J,2002,23 (Suppl) :265. 被引量：2
9Degertekin M,Saia F,Lemos PA,et al.Sirolimus-eluting stents for the treatment of in-stent restenosis.Minerva Cardioangiol,2003,51: 475-484. 被引量：1
10Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med,2002, 346:1773-1780. 被引量：2
